Bringing the fundamentals into focus…
Back to Eli Lilly and Company
How Eli Lilly and Company stacks up
LLY · against 1 other Healthcare companies of similar size
Growth
91/ 100
Near the top of its peers.
Ranked #1 of 2 · scores higher than 100% of peers
Bars: peers in each 10-point band of the growth score1 peers with a growth score of 90–100, including LLY · Click a bar to see the companies
Why growth scores 91?
Weighted metrics compared with all Healthcare companies.Mainly thanks to its 3-year revenue growth, revenue growth and earnings per share growth, which are stronger than most Healthcare peers.
- faster growth in earnings per share: stronger than 85% of peers. Earnings per share growth: 94.6% vs peer median 9.8%
- faster revenue growth over the last year: stronger than 90% of peers. Revenue growth: 49.6% vs peer median 6.1%
- faster revenue growth over three years: stronger than 91% of peers. 3-year revenue growth: 39.2% vs peer median 5.8%
Metric by metric
Position: dot = LLY, ranked from the worst peer (left) to the best (right); tick = middle, shaded = middle half of peers.| Metric | LLY | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Revenue growthHigher is better · 2 reported | 49.6% | 28.8% | 100% | 33% | |
| Earnings per share growthHigher is better · 2 reported | 94.6% | 43.7% | 100% | 33% | |
| 3-year revenue growthHigher is better · 2 reported | 39.2% | 24.3% | 100% | 33% |
Ranking by growth score
Top 5 and the companies ranked around LLY| Rank | Company | Market cap | Growth | Overall |
|---|---|---|---|---|
| 1 | 1.06T USD | 91 | 63 | |
| 2 | 622.8B USD | 48 | 59 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score